GENE ONLINE|News &
Opinion
Blog

SARS-CoV-2
COVID-19
COVID-19 Vaccine: Novavax Gets Funding from the US Department of Defense
2020-06-09
Combating the Pandemic with AI and Big Data: Highlights from the “TAIWAN is Helping: AI x Pandemic Prevention Online Forum”
2020-06-03Partner
COVID-19 Remdesivir
Remdesivir Registers Middling Benefit in Patients with Moderate COVID-19
2020-06-01
COVID-19 SARS
An Old SARS Antibody May Well be Our Weapon against COVID-19
2020-05-23
COVID-19 Vaccine
COVID-19: AstraZeneca Receives $1B from BARDA to Develop Oxford’s Coronavirus Vaccine
2020-05-23
COVID-19 Fibrinolysis
Links Between COVID-19 and Coagulopathy – A New Direction for COVID-19 Research
2020-05-22
COVID-19
COVID-19: Moderna Registers Positive Phase 1 Results for mRNA Vaccine
2020-05-18
COVID-19
A Review of Neurological Symptoms in COVID-19 Patients
2020-05-18
COVID-19 ACE2
ACE2: A Valuable Biomarker for COVID19 Susceptibility in Heart Patients
2020-05-16
COVID-19 Spike Protein
Mutations Observed in Coronavirus “Spike” Caution
2020-05-09
COVID-19
Researchers Report Inactivated COVID-19 Vaccine Confers Protection in Monkeys
2020-05-08
COVID-19 Antibody
Human Monoclonal Antibody Breakthroughs Provide New Hope against COVID-19
2020-05-06
COVID-19 Antibody
Llama Antibodies Show Promise as Probable Coronavirus Treatment
2020-05-05
COVID-19
AACR 2020: What Does Cancer Therapy Mean in the Time of COVID-19?
2020-05-04
COVID-19 Anti-COVID Drug
Potential Repurposed Drugs Currently in Evaluation for COVID-19
2020-05-01
1 … 5 6 7 8 9
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top